Clinical Implication of Morphological Subtypes in Management of Intraductal Papillary Mucinous Neoplasm

被引:45
|
作者
Yamada, Suguru [1 ]
Fujii, Tsutomu [1 ]
Shimoyama, Yoshie [2 ]
Kanda, Mitsuro [1 ]
Nakayama, Goro [1 ]
Sugimoto, Hiroyuki [1 ]
Koike, Masahiko [1 ]
Nomoto, Shuji [1 ]
Fujiwara, Michitaka [1 ]
Nakao, Akimasa [3 ]
Kodera, Yasuhiro [1 ]
机构
[1] Nagoya Univ, Sch Med, Dept Gastroenterol Surg Surg 2, Nagoya, Aichi 466, Japan
[2] Nagoya Univ Hosp, Dept Pathol, Nagoya, Aichi, Japan
[3] Nagoya Cent Hosp, Dept Surg, Nagoya, Aichi, Japan
关键词
INTERNATIONAL CONSENSUS GUIDELINES; PANCREATIC-JUICE CYTOLOGY; SURGICAL RESECTION; IPMN; CLASSIFICATION; TUMOR; RECURRENCE; PROGNOSIS; SURVIVAL;
D O I
10.1245/s10434-014-3565-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Morphological subtypes of intraductal papillary mucinous neoplasm (IPMN) have been established. Invasive IPMNs include colloid carcinoma and tubular carcinoma. Few studies have explored the association between the morphological and invasive subtypes in a large population. Clinical relevance of the morphological subtypes remains unclear. One hundred sixty-nine consecutive patients who underwent curative resection of IPMN were enrolled. The intraductal components were classified into four distinct epithelial subtypes: gastric, intestinal, pancreatobiliary, and oncocytic. The invasive components were classified as colloid or tubular. The numbers of patients with gastric, intestinal, pancreatobiliary, and oncocytic subtypes were 123, 42, 3, and 1, respectively. Fifty-six patients had invasive cancer (tubular type, 42; colloid type, 14). The proportions of gastric type IPMN within each histological grade were 88 % among adenomas, 43 % among noninvasive carcinomas, 41 % among minimally invasive carcinomas, and 74 % among invasive carcinomas. Gastric subtype was more commonly associated with branch duct type and intestinal subtype with main duct type, and these tendencies were statistically significant (P = 0.0131). Furthermore, there was a strong correlation between gastric and tubular types and between intestinal and colloid types (P < 0.0001). The 5-year survival rate among the 56 invasive cancers was 52.7 % for gastric type and 89.7 % for intestinal type, which was statistically significant (P = 0.030). Gastric type IPMN is mostly derived from branch duct IPMN and often demonstrates benign behavior, as seen with adenomas. However, once gastric type IPMN develops into invasive carcinoma, the survival rate is significantly lower than other types.
引用
收藏
页码:2444 / 2452
页数:9
相关论文
共 50 条
  • [1] The Clinical Management of Main Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas
    Dal Borgo, Chiara
    Perri, Giampaolo
    Borin, Alex
    Marchegiani, Giovanni
    Salvia, Roberto
    Bassi, Claudio
    DIGESTIVE SURGERY, 2019, 36 (02) : 104 - 110
  • [2] Intraductal Papillary Mucinous Neoplasm: Clinical Surveillance and Management Decisions
    Chin, Joanna Y.
    Pitman, Martha B.
    Hong, Theodore S.
    SEMINARS IN RADIATION ONCOLOGY, 2014, 24 (02) : 77 - 84
  • [3] Evaluation of Clinical Meaning of Histological Subtypes of Intraductal Papillary Mucinous Neoplasm of the Pancreas
    Kang, Mee Joo
    Lee, Kyoung Bun
    Jang, Jin-Young
    Han, In Woong
    Kim, Sun-Whe
    PANCREAS, 2013, 42 (06) : 959 - 966
  • [4] Strategy in intraductal papillary mucinous neoplasm of the pancreas
    Navarro Colas, Salvador
    Vaquero Raya, Eva C.
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2012, 35 (09): : 652 - 659
  • [5] Management of pancreatic intraductal papillary mucinous neoplasm
    Hoshi, Hisakazu
    Zaheer, Atif
    El Abiad, Rami G.
    Maxwell, Jessica E.
    Chu, Linda C.
    Gerke, Henning
    Chan, Carlos H.
    CURRENT PROBLEMS IN SURGERY, 2018, 55 (04) : 126 - 152
  • [6] Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes
    Mino-Kenudson, Mari
    Fernandez-del Castillo, Carlos
    Baba, Yoshifumi
    Valsangkar, Nakul P.
    Liss, Andrew S.
    Hsu, Maylee
    Correa-Gallego, Camilo
    Ingkakul, Thun
    Johnston, Rocio Perez
    Turner, Brian G.
    Androutsopoulos, Vasiliki
    Deshpande, Vikram
    McGrath, Deborah
    Sahani, Dushyant V.
    Brugge, William R.
    Ogino, Shuji
    Pitman, Martha B.
    Warshaw, Andrew L.
    Thayer, Sarah P.
    GUT, 2011, 60 (12) : 1712 - 1720
  • [7] Intraductal papillary mucinous neoplasm of the pancreas
    Rosendahl, J.
    Moessner, J.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (17) : 894 - 897
  • [8] Predictors of Recurrence in Intraductal Papillary Mucinous Neoplasm: Experience with 183 Pancreatic Resections
    Winner, Megan
    Epelboym, Irene
    Remotti, Helen
    Lee, James L.
    Schrope, Beth A.
    Chabot, John A.
    Allendorf, John D.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2013, 17 (09) : 1618 - 1626
  • [9] Interobserver variability in intraductal papillary mucinous neoplasm subtypes and application of their mucin immunoprofiles
    Kwak, Heewon. A.
    Liu, Xiuli
    Allende, Daniela S.
    Pai, Rish K.
    Hart, John
    Xiao, Shu-Yuan
    MODERN PATHOLOGY, 2016, 29 (09) : 977 - 984
  • [10] Intraductal papillary mucinous neoplasm of the pancreas - epidemiology, risk factors, diagnosis, and management
    Aronsson, Linus
    Andersson, Roland
    Ansari, Daniel
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (08) : 803 - 815